Gene · 1879
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review. | Antimicrob Agents Chemother | 2023 | 37195189 | PubTator, text mining | PubMed |
| Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification. | Nat Cell Biol | 2023 | 37188763 | PubTator, text mining | PubMed |
| Treatment and Response Evaluation Challenges in a Pregnant Woman With B-Cell Lymphoblastic Leukemia and Li-Fraumeni Syndrome. | J Hematol | 2023 | 37187497 | PubTator, text mining | PubMed |
| BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5. | Blood Adv | 2023 | 37184294 | PubTator, text mining | PubMed |
| Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases. | Front Oncol | 2023 | 37182123 | PubTator, text mining | PubMed |
| Hypoxia-inducible factor-1α regulates the interleukin-6 production by B cells in rheumatoid arthritis. | Clin Transl Immunology | 2023 | 37179532 | PubTator, text mining | PubMed |
| The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols. | Diagnostics (Basel) | 2023 | 37174980 | PubTator, text mining | PubMed |
| Integrins and the Metastasis-like Dissemination of Acute Lymphoblastic Leukemia to the Central Nervous System. | Cancers (Basel) | 2023 | 37173970 | PubTator, text mining | PubMed |
| Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles. | Front Neurol | 2023 | 37168665 | PubTator, text mining | PubMed |
| PTH regulates osteogenesis and suppresses adipogenesis through Zfp467 in a feed-forward, PTH1R-cyclic AMP-dependent manner. | Elife | 2023 | 37159501 | PubTator, text mining | PubMed |
| EBF1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity. | Int J Hematol | 2023 | 37149540 | PubTator, text mining | PubMed |
| Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. | Cell Stem Cell | 2023 | 37146584 | PubTator, text mining | PubMed |
| Characteristic and fate determination of adipose precursors during adipose tissue remodeling. | Cell Regen | 2023 | 37138165 | PubTator, text mining | PubMed |
| Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers. | Oncogene | 2023 | 37130917 | PubTator, text mining | PubMed |
| Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant-review article. | Ann Hematol | 2023 | 37129698 | PubTator, text mining | PubMed |
| Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma. | World J Clin Oncol | 2023 | 37124135 | PubTator, text mining | PubMed |
| Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway. | Chin Med J (Engl) | 2023 | 37114652 | PubTator, text mining | PubMed |
| Epstein-Barr Virus B Cell Growth Transformation: The Nuclear Events. | Viruses | 2023 | 37112815 | PubTator, text mining | PubMed |
| Innovative Strategies for Hair Regrowth and Skin Visualization. | Pharmaceutics | 2023 | 37111686 | PubTator, text mining | PubMed |
| The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome. | Leukemia | 2023 | 37100882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1879/papers?page=16